ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor-negative breast cancer patients

被引：3
|
作者：
Liu, Dingxie [1 ]
Hao, Qiongyu [2 ,3 ]
Li, Jieqing [2 ,3 ,4 ,5 ]
Li, Qun [6 ]
Wang, Kun [4 ,5 ]
Geng, Qing [7 ]
Wu, Yutong [1 ]
Vadgama, Jaydutt V. [2 ,3 ]
Wu, Yong [2 ,3 ]
机构：
[1] Bluewater Biotech LLC, POB 1010, New Providence, NJ 07974 USA
[2] Charles Drew Univ Med & Sci, David Geffen UCLA Sch Med, Dept Internal Med, Div Canc Res & Training, Los Angeles, CA 90095 USA
[3] UCLA Jonsson Comprehens Canc Ctr, 1748 E 118th St, Los Angeles, CA 90095 USA
[4] Guangdong Prov Peoples Hosp, Canc Ctr, Dept Breast Canc, Guangzhou 510080, Guangdong, Peoples R China
[5] Guangdong Acad Med Sci, Guangzhou 510080, Guangdong, Peoples R China
[6] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Oncol, Shanghai 200123, Peoples R China
[7] Wuhan Univ, Dept Thorac Surg, Renmin Hosp, Wuhan 430060, Hubei, Peoples R China
来源：
CANCER COMMUNICATIONS | 2022年 / 42卷 / 07期
关键词：
D O I：
10.1002/cac2.12296
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：663 / 667
页数：5
相关论文
共 50 条
  • [1] Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients
    Glynn, Sharon A.
    Boersma, Brenda J.
    Dorsey, Tiffany H.
    Yi, Ming
    Yfantis, Harris G.
    Ridnour, Lisa A.
    Martin, Damali N.
    Switzer, Christopher H.
    Hudson, Robert S.
    Wink, David A.
    Lee, Dong H.
    Stephens, Robert M.
    Ambs, Stefan
    JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (11): : 3843 - 3854
  • [2] Tamoxifen for patients with estrogen receptor-negative breast cancer
    Swain, SM
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (18) : 93S - 97S
  • [3] Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype
    Carmeci, C
    Thompson, DA
    Kuang, WW
    Lightdale, N
    Furthmayr, H
    Weigel, RJ
    SURGERY, 1998, 124 (02) : 211 - 217
  • [4] Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer
    Merkin, Ross D.
    Vanner, Elizabeth A.
    Romeiser, Jamie L.
    Shroyer, A. Laurie W.
    Escobar-Hoyos, Luisa F.
    Li, Jinyu
    Powers, Robert S.
    Burke, Stephanie
    Shroyer, Kenneth R.
    HUMAN PATHOLOGY, 2017, 62 : 23 - 32
  • [5] Overexpression of cyclinD1 predicts for poor prognosis in estrogen receptor-negative breast cancer patients
    Umekita, Y
    Ohi, Y
    Sagara, Y
    Yoshida, H
    INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (03) : 415 - 418
  • [6] β2-Adrenergic receptor expression is associated with biomarkers of tumor immunity and predicts poor prognosis in estrogen receptor-negative breast cancer
    Kurozumi, Sasagu
    Kaira, Kyoichi
    Matsumoto, Hiroshi
    Hirakata, Tomoko
    Yokobori, Takehiko
    Inoue, Kenichi
    Horiguchi, Jun
    Katayama, Ayaka
    Koshi, Hiromi
    Shimizu, Akira
    Oyama, Tetsunari
    Sloan, Erica K.
    Kurosumil, Masafumi
    Fujii, Takaaki
    Shirabe, Ken
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 177 (03) : 603 - 610
  • [7] β2-Adrenergic receptor expression is associated with biomarkers of tumor immunity and predicts poor prognosis in estrogen receptor-negative breast cancer
    Sasagu Kurozumi
    Kyoichi Kaira
    Hiroshi Matsumoto
    Tomoko Hirakata
    Takehiko Yokobori
    Kenichi Inoue
    Jun Horiguchi
    Ayaka Katayama
    Hiromi Koshi
    Akira Shimizu
    Tetsunari Oyama
    Erica K. Sloan
    Masafumi Kurosumi
    Takaaki Fujii
    Ken Shirabe
    Breast Cancer Research and Treatment, 2019, 177 : 603 - 610
  • [8] The prevalence of estrogen receptor-negative breast cancer in Ethiopia
    Eva Johanna Kantelhardt
    Assefa Mathewos
    Abreha Aynalem
    Tigeneh Wondemagegnehu
    Ahmedin Jemal
    Martina Vetter
    Erdme Knauf
    Anne Reeler
    Solomon Bogale
    Christoph Thomssen
    Andreas Stang
    Tufa Gemechu
    Pietro Trocchi
    Bekuretsion Yonas
    BMC Cancer, 14
  • [9] Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
    Ni, Min
    Chen, Yiwen
    Lim, Elgene
    Wimberly, Hallie
    Bailey, Shannon T.
    Imai, Yuuki
    Rimm, David L.
    Liu, X. Shirley
    Brown, Myles
    CANCER CELL, 2011, 20 (01) : 119 - 131
  • [10] Epigenetics of estrogen receptor-negative primary breast cancer
    Huynh, Kelly T.
    Chong, Kelly K.
    Greenberg, Edward S.
    Noon, Dave S. B.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2012, 12 (04) : 371 - 382
12345